Edition:
United Kingdom

Ambu A/S (AMBUb.CO)

AMBUb.CO on Copenhagen Stock Exchange

522.50DKK
3:59pm GMT
Change (% chg)

kr.1.50 (+0.29%)
Prev Close
kr.521.00
Open
kr.519.00
Day's High
kr.524.00
Day's Low
kr.515.00
Volume
41,600
Avg. Vol
80,153
52-wk High
kr.595.00
52-wk Low
kr.270.00

Chart for

About

Ambu A/S is a Denmark-based company engaged in the development, manufacture and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area... (more)

Overall

Beta: 0.45
Market Cap(Mil.): kr.23,432.60
Shares Outstanding(Mil.): 41.84
Dividend: 1.55
Yield (%): 0.28

Financials

  Industry Sector
P/E (TTM): -- 32.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.01 10.62
ROE: -- 16.85 14.20

BRIEF-Ambu A/S says to issue up to 1.3 mln B shares in private placement

* Reg-Ambu A/S: Ambu A/S to issue up to 1,255,000 B shares in a private placement Source text for Eikon: Further company coverage: ( Bangalore.newsroom@thomsonreuters.com )

14 Nov 2017

BRIEF-Ambu Q4 2016/17 EBIT up at DKK ‍134​ million

* Q4 2016/17 EBIT DKK ‍134​ MILLION VERSUS DKK 131 MILLION YEAR AGO

09 Nov 2017

BRIEF-Ambu buys Invendo Medical for EUR 225 million

* REG-AMBU ACQUIRES INVENDO MEDICAL AND ENTERS MARKET OF 70 MILLION GASTRO PROCEDURES ANNUALLY

25 Oct 2017

BRIEF-Ambu plans to ‍generate an EBIT margin of 24-25 pct in 2020

* ‍TOWARDS 2020 AMBU PLANS TO GROW ORGANICALLY BY 13-15% ANNUALLY AND EXPAND EBIT-MARGIN BY MORE THAN 5%-PTS​

04 Oct 2017

BRIEF-Ambu Q3 2016/17 EBIT up at DKK 130 million

* ‍OUTLOOK IS NOW FOR ORGANIC GROWTH OF APPROX. 14% AGAINST PREVIOUSLY ANNOUNCED OUTLOOK OF 12-14%​

23 Aug 2017

Earnings vs. Estimates